BRIDGEWATER, N.J.--(BUSINESS WIRE)--July 6, 2006--Enzon Pharmaceuticals Inc. (“Enzon”) announced today the completion of its tender offer for up to $180 million aggregate principal amount of its 4 1/2% Convertible Subordinated Notes due 2008 (the “Notes”), which expired Wednesday, July 5, 2006 at 5:00 p.m., New York City time. Enzon received valid tenders from holders of $137,581,000 aggregate principal amount and accepted all tenders validly made. As of today, $122,642,000 aggregate principal amount of Notes remain outstanding.
